WiLAN Subsidiary Acquires Medical Patent Portfolio

WiLAN Subsidiary Acquires Medical Patent Portfolio 
OTTAWA, CANADA -- (Marketwired) -- 06/10/14 --   Wi-LAN Inc. ("WiLAN"
or the "Company") (TSX: WIN)(NASDAQ: WILN) today announced that a
subsidiary has acquired a portfolio of medical patents that relate to
Stent technology. 
"With the acquisition of this medical technology, and a strong
opportunity pipeline, WiLAN is seeing significant demand from
inventors and small companies, in diverse markets, looking to
monetize their valuable inventions," said Jim Skippen, President &
CEO. "The acquired technology helps address vascular blood flow
complications." 
The acquisition of this portfolio will be funded through an upfront
payment and the sharing of net revenues generated by licensing the
patents. WiLAN can confirm that it does not consider the upfront
payment amount to be material relative to its current cash position.
All other terms of the agreement are confidential. 
About WiLAN 
WiLAN, founded in 1992, is a leading technology innovation and
licensing company. WiLAN has licensed its intellectual property to
over 280 companies worldwide. Inventions in our portfolio have been
licensed by companies that manufacture or sell a wide range of
communication and consumer electronics products including 3G and 4G
handsets, Wi-Fi-enabled laptops, Wi-Fi and broadband routers, xDSL
infrastructure equipment, cellular base stations and digital TV
receivers. For more information: www.wilan.com. 
Forward-looking Information 
This news release contains forward-looking statements and
forward-looking information within the meaning of the U.S. Private
Securities Litigation Reform Act of 1995 and other United States and
Canadian securities laws. The phrases "will be", "generated by" and
similar terms and phrases are intended to identify these
forward-looking statements. Forward-looking statements and
forward-looking information are based on estimates and assumptions
made by WiLAN in light of its experience and its perception of
historical trends, current conditions, expected future developments
and the expected effects of new business strategies and expected
future developments, as well as other factors that WiLAN believes are
appropriate in the circumstances. Many factors could cause WiLAN's
actual performance or achievements to differ materially from those
expressed or implied by the forward-looking statements or
forward-looking information. Such factors include, without
limitation, the risks described in WiLAN's February 3, 2014 annual
information form for the year ended December 31, 2013 (the "AIF").
Copies of the AIF may be obtained at www.sedar.com or www.sec.gov.
WiLAN recommends that readers review and consider all of these risk
factors and notes that readers should not place undue reliance on any
of WiLAN's forward-looking statements. WiLAN has no intention and
undertakes no obligation to update or revise any forward-looking
statements or forward-looking information, whether as a result of new
information, future events or otherwise, except as required by law. 
All trademarks and brands mentioned in this release are the property
of their respective owners. 
Contacts:
For media and investor inquiries,
Tyler Burns
Director, Investor Relations
O: 613.688.4330
C: 613.697.0367
E: tburns@wilan.com
 
 
Press spacebar to pause and continue. Press esc to stop.